STOCK TITAN

OraSure (OSUR) CFO granted stock awards and withholds shares for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

OraSure Technologies’ Chief Financial Officer Kenneth J. McGrath reported equity award activity in company stock. On March 1 and March 2, he acquired 88,348 and 26,814 shares of common stock at $0.00 per share through grants and settlement of vested performance units and restricted stock. On March 1, 7,639 and 20,745 shares were withheld at $3.0425 per share to cover tax liabilities tied to these vestings, rather than open-market sales. After these transactions, he directly owned 535,241 shares. The newly granted restricted stock is scheduled to vest in three equal annual installments beginning on March 2, 2027, conditioned on his continued service.

Positive

  • None.

Negative

  • None.

Insights

CFO activity reflects routine equity awards and tax withholding, not open-market trading.

The transactions show OraSure Technologies CFO Kenneth J. McGrath receiving equity compensation via restricted stock and performance units. The large grants at $0.00 per share are standard for stock-based awards and increase his direct share ownership to 535,241 shares.

The dispositions coded "F" at $3.0425 per share are share withholdings to satisfy tax obligations on vesting, rather than discretionary selling into the market. The new restricted stock vests annually starting March 2, 2027, tying part of his compensation to ongoing service and the company’s share price over time.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McGrath Kenneth J

(Last) (First) (Middle)
C/O ORASURE TECHNOLOGIES, INC.
220 EAST FIRST STREET

(Street)
BETHLEHEM PA 18015

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ORASURE TECHNOLOGIES INC [ OSUR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/01/2026 A 26,814(1) A $0 475,277 D
Common Stock 03/01/2026 F 7,639(2) D $3.0425 467,638 D
Common Stock 03/01/2026 F 20,745(3) D $3.0425 446,893 D
Common Stock 03/02/2026 A 88,348(4) A $0 535,241 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares delivered in settlement of vested performance units that did not constitute a derivative security.
2. Withholding of shares to pay tax liability associated with the vesting of performance units.
3. Withholding of shares to pay the tax liability associated with vesting of restricted shares.
4. Grant of restricted stock award vesting in three equal annual installments beginning on March 2, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates.
/s/ Michele Anthony, Attorney-In-Fact 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did OraSure Technologies (OSUR) CFO Kenneth McGrath report in this Form 4?

The filing shows Kenneth McGrath received common stock through equity awards and performance unit settlements, and had shares withheld to cover related taxes. These actions increased his direct holdings to 535,241 shares, reflecting routine compensation activity rather than open-market buying or selling.

How many OraSure Technologies (OSUR) shares did the CFO acquire through awards?

Kenneth McGrath acquired 88,348 and 26,814 shares of OraSure Technologies common stock at $0.00 per share. These shares came from settlement of vested performance units and a new restricted stock grant as part of his equity compensation package, subject to future vesting conditions.

Were any OraSure Technologies (OSUR) shares sold on the open market in this Form 4?

The filing does not show open-market sales. Instead, 7,639 and 20,745 shares were disposed of at $3.0425 per share to cover tax liabilities on vesting awards. These "F"-coded transactions are tax-withholding dispositions, not discretionary sales into the market.

What is the vesting schedule for the CFO’s new OraSure Technologies (OSUR) restricted stock grant?

The new restricted stock award granted to Kenneth McGrath vests in three equal annual installments beginning on March 2, 2027. Vesting is conditioned on his continuous service with OraSure Technologies through each applicable vesting date, aligning incentives with longer-term employment.

How did these transactions change the OraSure Technologies (OSUR) CFO’s ownership?

Following the reported grants, settlements, and tax withholdings, Kenneth McGrath directly owned 535,241 shares of OraSure Technologies common stock. The combination of new awards and tax-related share dispositions resulted in a net increase in his reported direct holdings.

What do the tax-withholding transactions mean in the OraSure Technologies (OSUR) Form 4?

The Form 4 notes that certain shares were withheld to pay tax liabilities tied to vesting performance units and restricted shares. This means the company used a portion of vested shares, valued at $3.0425 each, to satisfy taxes instead of requiring separate cash payments.
Orasure Tech

NASDAQ:OSUR

OSUR Rankings

OSUR Latest News

OSUR Latest SEC Filings

OSUR Stock Data

214.12M
67.32M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
BETHLEHEM